These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25775472)

  • 1. Generic switching and non-persistence among medicine users: a combined population-based questionnaire and register study.
    Rathe J; Andersen M; Jarbøl DE; dePont Christensen R; Hallas J; Søndergaard J
    PLoS One; 2015; 10(3):e0119688. PubMed ID: 25775472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of generic switching on concerns about medicine and non-persistence among Danish adults in a general practice setting.
    Rathe JØ
    Dan Med J; 2015 Oct; 62(10):B5148. PubMed ID: 26441397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between generic substitution and patients' attitudes, beliefs and experiences.
    Rathe J; Larsen P; Andersen M; Paulsen M; Jarbøl D; Thomsen J; Soendergaard J
    Eur J Clin Pharmacol; 2013 Oct; 69(10):1827-36. PubMed ID: 23765409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' concern about their medicine after a generic switch: a combined cross-sectional questionnaire and register study.
    Rathe J; Søndergaard J; Jarbøl DE; Hallas J; Andersen M
    Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):965-73. PubMed ID: 24946275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Switch-to-Brand Rates as a Potential Signal for Therapeutic Equivalency of Generic Antidepressants: A Real-World Retrospective Cohort Study.
    Kalaria S; Spence O; Hong K; dosReis S; Gopalakrishnan M
    Clin Pharmacol Ther; 2021 Aug; 110(2):443-451. PubMed ID: 33811324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic substitution of antiepileptic drugs--a survey of patients' perspectives in Germany and other German-speaking countries.
    Hensler K; Uhlmann C; Porschen T; Benecke R; Rösche J
    Epilepsy Behav; 2013 Apr; 27(1):135-9. PubMed ID: 23416284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is associated with increased side effects and lower perceived efficacy following switching to a generic medicine? A New Zealand cross-sectional patient survey.
    MacKrill K; Petrie KJ
    BMJ Open; 2018 Oct; 8(10):e023667. PubMed ID: 30341138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact on health outcomes and healthcare utilisation of switching to generic medicines consequent to reference pricing: the case of lamotrigine in New Zealand.
    Lessing C; Ashton T; Davis P
    Appl Health Econ Health Policy; 2014 Oct; 12(5):537-46. PubMed ID: 25005492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic substitution of antidiabetic drugs in the elderly does not affect adherence.
    Trotta F; Da Cas R; Maggini M; Rossi M; Traversa G
    Ann Ist Super Sanita; 2014; 50(4):333-40. PubMed ID: 25522073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover study.
    Kesselheim AS; Bykov K; Gagne JJ; Wang SV; Choudhry NK
    Neurology; 2016 Oct; 87(17):1796-1801. PubMed ID: 27683844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK; Kruzikas DT; McLaughlin TP
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes.
    Andermann F; Duh MS; Gosselin A; Paradis PE
    Epilepsia; 2007 Mar; 48(3):464-9. PubMed ID: 17346246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy.
    Erickson SC; Le L; Ramsey SD; Solow BK; Zakharyan A; Stockl KM; Harada AS; Curtis B
    Epilepsia; 2011 Jul; 52(7):1365-71. PubMed ID: 21692778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between automatic generic substitution and treatment persistence with oral bisphosphonates.
    Ström O; Landfeldt E
    Osteoporos Int; 2012 Aug; 23(8):2201-9. PubMed ID: 22120909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
    Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing a statin switching programme in primary care: patients' views and experiences.
    Krska J; Allison K; Delargy M; Murray L; Smith H
    Br J Clin Pharmacol; 2012 Jul; 74(1):147-53. PubMed ID: 22257274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switch-backs associated with generic drugs approved using product-specific determinations of therapeutic equivalence.
    Gagne JJ; Polinski JM; Jiang W; Dutcher SK; Xie J; Lii J; Fulchino LA; Kesselheim AS
    Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):944-52. PubMed ID: 27102378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing drug switching and changes in low-density lipoprotein-cholesterol levels with atorvastatin: a real-world observational study.
    Lim YC; Lee EK; Park MH
    Lipids Health Dis; 2023 Sep; 22(1):151. PubMed ID: 37705044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.
    Wu EQ; Yu AP; Lauzon V; Ramakrishnan K; Marynchenko M; Ben-Hamadi R; Blum S; Erder MH
    Ann Pharmacother; 2011 Apr; 45(4):441-51. PubMed ID: 21415162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting.
    Markoula S; Chatzistefanidis D; Gatzonis S; Siatouni A; Siarava E; Verentzioti A; Kyritsis AP; Patsalos PN
    Seizure; 2017 May; 48():1-6. PubMed ID: 28363098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.